Polypropylene Raw Material for Meltblown PP Meltblown Filter
| FOB Price: | US$50,000.00 / Ton |
|---|---|
| Min. Order: | 1 Ton |
| Min. Order | FOB Price |
|---|---|
| 1 Ton | US$50,000.00/ Ton |
| Port: | Shenzhen, China |
|---|---|
| Transport Package: | Carton |
| Payment Terms: | L/C, T/T, D/P, Western Union, Paypal, Money Gram |
Product Description
Company Info
Address:
No. 186, Hayao Road, Daoli District, Harbin City, Heilongjiang Province, Harbin, Heilongjiang, China
Business Type:
Manufacturer/Factory
Business Range:
Health & Medicine, Security & Protection
Management System Certification:
ISO 9001, ISO 9000
Company Introduction:
China National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large healthcare group directly under the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, with 128, 000 employees and a full chain in the industry covering R&D, manufacturing, logistics and distribution, retail chains, healthcare, engineering services, exhibitions and conferences, international business and financial services.
Sinopharm owns over 1, 100 subsidiaries and 6 listed companies which are Sinopharm Group Co., Ltd. (Sinopharm Holding), China National Medicines Corporation Ltd., China National Accord Medicines Corporation Ltd., Beijing Tiantan Biological Products Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd., and China Traditional Chinese Medicine Holdings Co., Ltd.
The past years witnessed Sinopharm′s steady and sound development. From 2009to 2018, the CAGR of revenue and total assets reached 24.24% and 30.54% respectively. Sinopharm ranked 169th in Fortune Global 500 and the revenue of 2018 amounted to nearly 400 billion yuan...
Sinopharm has built a nationwide logistic and distributing network for drugs and medical devices and equipment, including 5logistic hubs, more than 40 provincial-level centers and over 240 municipal-level logistic sites. By establishing the smart medical service system, Sinopharmdelivers quality servicesto more than 230, 000 corporate clients.
Sinopharm owns over 1, 100 subsidiaries and 6 listed companies which are Sinopharm Group Co., Ltd. (Sinopharm Holding), China National Medicines Corporation Ltd., China National Accord Medicines Corporation Ltd., Beijing Tiantan Biological Products Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd., and China Traditional Chinese Medicine Holdings Co., Ltd.
The past years witnessed Sinopharm′s steady and sound development. From 2009to 2018, the CAGR of revenue and total assets reached 24.24% and 30.54% respectively. Sinopharm ranked 169th in Fortune Global 500 and the revenue of 2018 amounted to nearly 400 billion yuan...
Sinopharm has built a nationwide logistic and distributing network for drugs and medical devices and equipment, including 5logistic hubs, more than 40 provincial-level centers and over 240 municipal-level logistic sites. By establishing the smart medical service system, Sinopharmdelivers quality servicesto more than 230, 000 corporate clients.
